Topics

AstraZeneca Chooses China for R&D and AI Centers, $1B Biotech Fund

13:08 EST 6 Nov 2019 | Xconomy

AstraZeneca says it will establish centers for drug research and artificial intelligence development in China. The pharmaceutical giant has also set up a $1 billion fund to foster biotech innovation in that country. The move – which was announced at the China International Import Expo this week – will see the AstraZeneca found a global […]

Original Article: AstraZeneca Chooses China for R&D and AI Centers, $1B Biotech Fund

NEXT ARTICLE

More From BioPortfolio on "AstraZeneca Chooses China for R&D and AI Centers, $1B Biotech Fund"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...